Article Details
Retrieved on: 2022-05-19 19:46:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19. US2U Consulting May 2022 E-news News.
Article found on: www.cambridgenetwork.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here